Clover Health Investments, Corp. (CLOV) research: valuation against peers, fundamentals over time, risk and news coverage
CLOV
Clover Health Investments, Corp.No data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- MARKET REPORTBULLISHClover Posts Record H2 As Margins Widen To 35.5%
Clover's FY26 revenue topped guidance and margins surged to 35.5% in its record H2 2026, driven by new product lines.
- SPECIAL REPORTNEUTRALInsider Trading Splits Along Company Size: Small-Caps Buy, Larger Firms See Bigger Sales
A batch of insider filings shows small-company executives making modest purchases while insiders at larger, better-known firms executed sales ranging from hundreds of thousands to over $4 million.
- SPECIAL REPORTBEARISHInsider Selling Wave Sweeps US Mid-Caps as Executives Trim Into Strength
A dense batch of Form 4 disclosures over the past 24 hours points to broad-based insider distribution across financials, gaming, healthcare and industrials — a classic late-cycle signature that institutional desks watch for confirmation of stretched valuations.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.